Niagen Bioscience (NAGE) Retained Earnings (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Retained Earnings data on file, last reported at -$158.2 million in Q1 2026.

• Retained Earnings for Q1 2026 came in at -$158.2 million, up 10.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$158.2 million (up 10.54% YoY), and the FY2025 annual result was -$164.5 million, up 9.56% from the prior year.
• Retained Earnings advanced to -$158.2 million in Q1 2026 per NAGE's latest filing, from -$164.5 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$158.2 million in Q1 2026 and troughed at -$191.0 million in Q2 2024.
• A 5-year average of -$181.3 million and a median of -$184.1 million in 2022 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings dropped 18.3% in 2022, then grew 10.8% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$185.5 million in 2022, then slipped by 2.68% to -$190.5 million in 2023, then advanced by 4.49% to -$181.9 million in 2024, then grew by 9.56% to -$164.5 million in 2025, then grew by 3.84% to -$158.2 million in 2026.
• Business Quant data shows NAGE's Retained Earnings at -$158.2 million in Q1 2026, -$164.5 million in Q4 2025, and -$168.7 million in Q3 2025.